St. Louis (October 1, 2002) - Divergence, Inc. was a presenting company at the BIO Venture Forum in San Francisco, California today. This annual conference is the largest of its kind and less than a third of the applying companies were selected to present. BIO is the Biotechnology Industry Organization.

"Participating in this conference is a great opportunity for Divergence," said Derek Rapp, Chief Executive Officer of Divergence and forum presenter. "Being recognized as a company with significant science targeting large, promising markets is a meaningful accomplishment."

"We expect to continue to cultivate relationships with sophisticated investors, and we hope those relationships will lead to financing at attractive terms," continued Rapp. "We are proud that the Divergence team has accomplished a great deal in discovery, development, and intellectual property creation around parasite control and that it has done so efficiently. We are determined to continue to operate at a high level."

Divergence, Inc. is a research and development company dedicated to the discovery of effective and ecologically sound strategies for the control of parasites and other pests. The company's initial focus is on parasitic nematodes, one of the world's major pest groups. Nematodes are roundworms that cause billions of dollars in damage annually to numerous crops, including corn, soybeans, cotton, strawberries and bananas. Nematodes also cause widespread disease in animals, including infections such as heartworm in dogs and cats and intestinal worms in livestock. Nematode-induced human diseases include elephantiasis and African river blindness.

For more information on Divergence, visit www.divergence.com.